AstraZeneca Profit Drops on Decline in Blockbuster-Drug Revenue

U.K. drug maker AstraZeneca, battling declining sales of its blockbuster cholesterol pill, posted lower revenue and profit in the first quarter of the year.

from WSJ.com: US Business http://ift.tt/2pCqqwY
via IFTTT